Search

everythinglearnresearchcommunity

for

Search:↓

Rare ULBP3 gene changes may raise the risk of Alopecia areata, a certain FAS gene deletion could cause a dysfunctional protein in an immune disorder, and having one copy of a specific genetic deletion is okay, but two copies cause sickle cell disease.

Lowering HER2 levels with certain drugs may reduce metabolic syndrome risk in women.

Finasteride use is linked to a higher risk of memory problems.

Higher doses of 5α-reductase inhibitors may lower mortality risk, but low doses increase it.

Finasteride treats hair loss and reduces prostate cancer risk.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

The study found that alopecia areata and hypothyroidism increase the risk of each other, but androgenetic alopecia and hypothyroidism do not.

Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

AI-enhanced smart patches can personalize drug delivery for better treatment outcomes.

Glutamine may protect against alopecia areata, while certain cholesterol and glucose levels may increase risk.

Men with male pattern baldness may have a slightly higher risk of prostate cancer.

Alopecia areata may be linked to higher heart disease risk.

Adults should not consume more than 255 micrograms of selenium per day to avoid risk of hair loss and other side effects.

Genetic variations greatly affect individual metabolism and can impact health and disease risk.

Certain genetic variations in IGF2BP2 and IGFBP3 are linked to a higher risk of PCOS.

Certain gut bacteria may protect against hair loss, while others may increase the risk.

Copper may protect against alopecia areata, while certain inflammatory markers increase risk.

MX1 and AR genes are linked to milder COVID-19, while TMPRSS2 increases severe risk, especially in women.

The roadmap calls for better research and funding to improve PCOS diagnosis, treatment, and health outcomes.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Certain surgical methods are better than routine incision for hidradenitis suppurativa, topical clindamycin and acitretin are effective treatments, men with HS have a risk of skin cancer, HS patients are more likely to die from heart problems, and specific genetic markers are linked to treatment response.

Oral contraceptives provide various health benefits beyond birth control, including managing menstrual issues, skin conditions, pain, and reducing the risk of certain cancers.

Digital health education may reduce stress, anxiety, and depression in PCOS patients.

Alopecia areata patients need better education to improve their disease management.

Providing housing and case management reduces hospital visits for chronically ill homeless adults.

Surgical robots have improved but still can't perform tasks or make decisions on their own.

Burn care for the elderly needs improvement, with more research and specific guidelines required.

Alopecia areata affects 1.45% of people in Japan, impacting mood and self-esteem, with many not seeking treatment.